Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05606939

The Role of Intestinal Ultrasound in Monitoring the Response to Biological Therapy in Patients With Ulcerative Colitis

Conditions: Ulcerative Colitis

Sex: All
Ages: 18 Years – 75 Years
Enrollment: 100
Sponsor: Assiut University

Summary

In this study, the investigators aim to evaluate the role of intestinal ultrasound in evaluation of the therapeutic response to biological therapy in patient with ulcerative colitis

Eligibility Criteria

Inclusion Criteria:Any patient above age of 18 years old and diagnosed to have UC and whom not responding to conventional medical therapy and eligible for biological therapy will be recruited in this studymoderate to severe UC patientsimmunosuppressant or corticosteroid refractory diseasethose with intolerance or contraindication to conventional therapies are eligible to be treated with biological therapyExclusion Criteria:Patients with UC who are under age of 18 years' oldPatients with UC who aren't eligible to biological therapypatients with complication of UC(fistula , intestinal obstruction , intestinal perforation ,……)Patient refuse to participate in the study.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05606939). StuddyBuddy aggregates publicly available trial information.